tetano
Editor, Senior Moderator
Adv Rheumatol
. 2022 Feb 21;62(1):6.
doi: 10.1186/s42358-022-00237-4.
Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): a Brazilian cohort
André Cavalcanti[SUP] 1 [/SUP], Aline Islabão[SUP] 2 [/SUP], Cristina Magalhães[SUP] 3 [/SUP], Sarah Veloso[SUP] 2 [/SUP], Marlon Lopes[SUP] 2 [/SUP], Rogério do Prado[SUP] 4 [/SUP], Bruna Aquilante[SUP] 5 [/SUP], Ana Maria Terrazas[SUP] 6 [/SUP], Maria Fernanda Rezende[SUP] 6 [/SUP], Gleice Clemente[SUP] 6 [/SUP], Maria Teresa Terreri[SUP] 6 [/SUP]
Affiliations
Abstract
Background: Paediatric inflammatory multisystem syndrome (PIMS) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been described since mid-April 2020 with the first reports coming from Europe. Our objective was to describe the characteristics of patients among the Brazilian population.
Methods: A multicenter retrospective study was conducted with the participation of five pediatric rheumatology centers in Brazil during the period from March to November 2020. Children and adolescents with PIMS temporally associated with SARS-CoV-2 (TS) who met the definition criteria for the disease according to the Royal College of Paediatrics and Child Health were included. Demographic, clinical, laboratory, therapeutic characteristics and molecular and serological diagnosis of SARS-CoV-2 infection were described.
Results: Fifty-seven children and adolescents with PIMS-TS were evaluated, 54% female, with a median age of 8 (3-11) years. Most (86%) were previously healthy, with asthma being the main comorbidity, present in 10% of the patients. Fever was the main manifestation, present in all patients, followed by mucocutaneous and gastrointestinal features, present in 89% and 81% of the patients, respectively. Myocarditis occurred in 21% of the patients and in 68% of them required intensive care. The Kawasaki disease phenotype occurred in most patients (77%). All patients had elevated inflammatory markers, with elevated CRP being the most found (98%). Anemia and lymphopenia were present in 79% and 72%, respectively. Laboratory evidence of SARS-CoV-2 was found in 77% of the patients, with 39% positive RT-PCR and 84% positive serology for SARS-CoV-2. An immunomodulatory treatment was performed in 91% of the patients, with 67% receiving intravenous immunoglobulin (IVIG) associated with glucocorticoid, 21% receiving IVIG, and 3.5% receiving glucocorticoid. The median length of hospitalization was 10 days.
Conclusions: This study showed a high morbidity of PIMS-TS in Brazilian children, with a prolonged length of hospitalization and a high rate of admission to pediatric intensive care unit. Multicenter prospective studies are needed to assess the morbidity of the disease in the medium and long term.
Keywords: COVID-19; Kawasaki disease; Paediatric inflammatory multisystem syndrome; SARS-CoV-2.
. 2022 Feb 21;62(1):6.
doi: 10.1186/s42358-022-00237-4.
Paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS): a Brazilian cohort
André Cavalcanti[SUP] 1 [/SUP], Aline Islabão[SUP] 2 [/SUP], Cristina Magalhães[SUP] 3 [/SUP], Sarah Veloso[SUP] 2 [/SUP], Marlon Lopes[SUP] 2 [/SUP], Rogério do Prado[SUP] 4 [/SUP], Bruna Aquilante[SUP] 5 [/SUP], Ana Maria Terrazas[SUP] 6 [/SUP], Maria Fernanda Rezende[SUP] 6 [/SUP], Gleice Clemente[SUP] 6 [/SUP], Maria Teresa Terreri[SUP] 6 [/SUP]
Affiliations
- PMID: 35189972
- DOI: 10.1186/s42358-022-00237-4
Abstract
Background: Paediatric inflammatory multisystem syndrome (PIMS) associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been described since mid-April 2020 with the first reports coming from Europe. Our objective was to describe the characteristics of patients among the Brazilian population.
Methods: A multicenter retrospective study was conducted with the participation of five pediatric rheumatology centers in Brazil during the period from March to November 2020. Children and adolescents with PIMS temporally associated with SARS-CoV-2 (TS) who met the definition criteria for the disease according to the Royal College of Paediatrics and Child Health were included. Demographic, clinical, laboratory, therapeutic characteristics and molecular and serological diagnosis of SARS-CoV-2 infection were described.
Results: Fifty-seven children and adolescents with PIMS-TS were evaluated, 54% female, with a median age of 8 (3-11) years. Most (86%) were previously healthy, with asthma being the main comorbidity, present in 10% of the patients. Fever was the main manifestation, present in all patients, followed by mucocutaneous and gastrointestinal features, present in 89% and 81% of the patients, respectively. Myocarditis occurred in 21% of the patients and in 68% of them required intensive care. The Kawasaki disease phenotype occurred in most patients (77%). All patients had elevated inflammatory markers, with elevated CRP being the most found (98%). Anemia and lymphopenia were present in 79% and 72%, respectively. Laboratory evidence of SARS-CoV-2 was found in 77% of the patients, with 39% positive RT-PCR and 84% positive serology for SARS-CoV-2. An immunomodulatory treatment was performed in 91% of the patients, with 67% receiving intravenous immunoglobulin (IVIG) associated with glucocorticoid, 21% receiving IVIG, and 3.5% receiving glucocorticoid. The median length of hospitalization was 10 days.
Conclusions: This study showed a high morbidity of PIMS-TS in Brazilian children, with a prolonged length of hospitalization and a high rate of admission to pediatric intensive care unit. Multicenter prospective studies are needed to assess the morbidity of the disease in the medium and long term.
Keywords: COVID-19; Kawasaki disease; Paediatric inflammatory multisystem syndrome; SARS-CoV-2.